Publications & Resources

Get insights and guidance from MLMIC and other leading sources on medical professional liability, risk management, and more.

Tag: patient care

Patient Photos Displayed in EHRs Can Enhance Patient Safety

A new study published by JAMA Network Open says displaying patient photographs in EHRs can reduce wrong-patient order entry errors.

HHS Expands Telehealth Coverage of COVID-19 Countermeasures

HHS confirms physicians can deliver telehealth services across state lines for covered services to fight the spread of COVID-19.

Telehealth and Cybersecurity Considerations

As physicians continue to deliver care via telehealth, healthcare systems are strongly encouraged to adopt practices that can help reduce the risk of privacy breaches or cyberattacks related to the use of the technology.

New Guidance on Glucose Monitoring Tools Can Help Diabetic Patients Exercise Safely

Physicians can now turn to new guidance when advising diabetic patients on how to use modern glucose monitoring devices to exercise safely.

FDA Grants an EUA for Bamlanivimab to Treat COVID-19 Patients Who Meet Certain Criteria

The U.S. Food and Drug Administration has granted Eli Lilly and Company an emergency use authorization for bamlanivimab to treat mild-to-moderate COVID-19 in adult and pediatric patients.

How Good Oral Health Can Reduce Ventilator-Associated Pneumonia

Ventilator-associated pneumonia (VAP) is serious and deadly, but good oral healthcare can substantially reduce the likelihood that individuals connected to a mechanical ventilator contract VAP.

Prediction Tools to Manage and Treat COVID-19

To support policyholders as they navigate the pandemic, MLMIC has assembled a summary of predictive tools and technology to guide management and treatment of COVID-19.

Study Says Improved Treatment for COVID-19 is Reducing Mortality Rates

Improved treatment of COVID-19 is reducing mortality rates among those hospitalized for the infection, but experts caution the virus remains dangerous.

FDA Approves Veklury for Treatment of COVID-19 Patients Who Meet Certain Criteria

The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.

NIHR Identifies Four Syndromes Commonly Experienced by Patients With “Long COVID”

Based on a series of patient testimonials, the National Institute for Health Research says that ‘long COVID’ could actually be up to four different syndromes.